2016
DOI: 10.5812/jssc.66527
|View full text |Cite
|
Sign up to set email alerts
|

Herbal Drugs with Promising Anti-Leishmanial Activity: New Hope for Leishmaniasis Treatment

Abstract: Context: Leishmaniasis is one of the most common parasitic diseases. Many medicinal plants have been utilized for the treatment of leishmaniasis. Evidence Acquisition: Recent clinical trials have proven the efficacy of a number of herbal drugs. Synthetic agents and current drugs on the market have some disadvantages, such as side effects, high cost, and painful injections. Given the efficiency of herbal drugs, they can be a source of natural and harmless compounds for Leishmania treatment. Results: Several res… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2018
2018
2020
2020

Publication Types

Select...
3

Relationship

1
2

Authors

Journals

citations
Cited by 3 publications
(1 citation statement)
references
References 22 publications
0
1
0
Order By: Relevance
“…The usual and common treatment of leishmaniasis is the prescription of pentavalent antimony (antimonials) including Pentostam (sodium stibogluconate) or Glucantime (meglumine antimoniate) which have remained the first‐line chemical drugs against leishmaniasis globally . Another alternative first‐line treatment is antifungal drug amphotericin B (AMB) which is used in the case of resistance to the antimony treatment . Recently, new chemical therapeutic alternatives have been recommended for the treatment of leishmaniasis including lipid‐associated AMB, paromomycin, miltefosine, sitamaquine, azoles and itraconazole .…”
Section: Introductionmentioning
confidence: 60%
“…The usual and common treatment of leishmaniasis is the prescription of pentavalent antimony (antimonials) including Pentostam (sodium stibogluconate) or Glucantime (meglumine antimoniate) which have remained the first‐line chemical drugs against leishmaniasis globally . Another alternative first‐line treatment is antifungal drug amphotericin B (AMB) which is used in the case of resistance to the antimony treatment . Recently, new chemical therapeutic alternatives have been recommended for the treatment of leishmaniasis including lipid‐associated AMB, paromomycin, miltefosine, sitamaquine, azoles and itraconazole .…”
Section: Introductionmentioning
confidence: 60%